Central role of glycosylation processes in human genetic susceptibility to SARS-CoV-2 infections with Omicron variants

Geller F, Wu X, Lammi V, Abner E, Valliere JT, Nastou K, Rasmussen M, Worm Andersson N, Quinn L, DBDS Genomic Consortium, Aagaard B, Banasik K, Bliddal S, Boding L, Brunak S, Brøns N, Bybjerg-Grauholm J, Arregui Nordahl Christoffersen L, Didriksen M, Dinh KM, Erikstrup C, Feldt-Rasmussen U, Grønbæk K, Kaspersen KA, Mikkelsen C, Nielsen CH, Svarre Nielsen H, Dam Nielsen S, Nissen J, Burgos Sequeros C, Tommerup N, Ullum H, Estonian Biobank Research Team, FinnGen, Spiliopoulos L, Bager P, Hviid A, Sørensen E, Pedersen OB, Lane JM, Lassaunière R, Ollila HM, Ostrowski SR, Feenstra B.
medRxiv 2024.11.21.24317689; doi: https://doi.org/10.1101/2024.11.21.24317689
Preprint
Nov 21, 2024